In short. Botulinum toxin onset is gradual, with full effect at about two weeks and visible change usually starting around day three to seven. The plateau most patients value runs from roughly week three to week eight, after which movement returns gradually and most people are back to baseline somewhere between months three and six.
Key points
- Visible change usually starts around day three to seven, and full effect is at about two weeks.
- Movement softens before lines do, so a line may persist while frowning already feels weaker.
- The plateau runs from roughly week three to week eight, which is when lines look their best.
- Most people are back to baseline somewhere between months three and six.
- A maintenance interval set from your own response suits better than a fixed calendar.
Why the answer is a curve, not a number
Onset and duration are the two facts patients most want and most often receive vaguely. The honest answer is a curve rather than a number, and knowing its shape prevents most of the disappointment that follows a first treatment.
Days zero to three: nothing yet
The treatment is complete before you leave, but the effect is not. The substance binds at the nerve endings over the following days, and there is no visible change in this window. Anything that appears to be happening at this stage is swelling, or the natural tendency to inspect your face more closely than usual. Patients who judge the result now usually judge it wrongly, in both directions.
Days three to seven: movement changes first
Movement starts to soften. The important detail is that movement changes before lines do. You may notice that frowning feels weaker while the line itself is still visible, which is normal and does not mean the treatment has failed. The line responds to the reduced folding over the following days.
Days ten to fourteen: the point to judge
This is when the result is fully expressed for most patients, and it is the point at which it should be judged. A review visit in this window is what allows a conservative first plan to be refined: a small amount added to an area that responded less than expected is straightforward, whereas correcting an over-treated area is not.
The plateau from week three to week eight
The phase most patients actually value runs from roughly week three to week eight, when treated movement is at its most reduced and the lines look their best. Everything before that is onset and everything after it is decline. Understanding this makes the maintenance interval obvious rather than arbitrary.
| Phase | What you notice | What it means | What to do |
|---|---|---|---|
| Days zero to three | No visible change | The substance is binding at the nerve endings | Do not judge the result yet |
| Days three to seven | Movement softens while the line is still visible | Movement changes before lines do | Continue to wait |
| Days ten to fourteen | Full effect for most patients | The point at which the result should be judged | A review visit can refine a conservative plan |
| Week three to week eight | Treated movement at its most reduced | The plateau patients are paying for | Nothing; this is the result |
| Months two to four | Movement returns, often where it responded least | The decline is the treatment working as designed | Plan the next interval |
| Months three to six | Back to baseline for most people | Variation is real and individual | Set the interval from your own response |
What happens between months two and six?
Movement returns gradually and usually first in the areas that responded least. Patients often notice they can frown again before they notice the line returning. The decline is not a failure of the treatment; it is the treatment working as designed, and it is the same mechanism that makes an unwanted effect temporary. Most patients are back to where they started somewhere between months three and six, though some report a longer tail and a few a shorter one. The variation is real and is influenced by the area treated, the movement pattern and individual metabolism. The first course of treatment is as much a measurement of your own response as it is a treatment.
How is a maintenance interval chosen?
A calendar fixed at a standard number of months suits the average patient and nobody in particular. A better plan sets your interval from your own response: you return when the movement has returned enough to bother you, or at a review the physician recommends, rather than on a date chosen in advance.
When to contact the team rather than wait
A drooping eyelid, double vision, or weakness spreading beyond the treated area needs prompt review. Difficulty breathing, difficulty swallowing or slurred speech needs emergency care. Severe pain, spreading redness or fever at an injection site should be reported.
Sources
- American Academy of Dermatology: patient information on botulinum toxin
- British Association of Dermatologists: patient information on botulinum toxin treatment
- Cochrane Library: systematic reviews on botulinum toxin for facial lines
Internal links
Frequently asked questions
Why has nothing happened two days after treatment?
Because the effect has not begun yet. The substance binds at the nerve endings over the first days, and visible change usually starts at around day three to seven. Anything you notice at day two is swelling or expectation rather than the treatment working.
When should I judge the result?
At about two weeks. That is when the effect is fully expressed for most patients, and it is the earliest sensible point to decide whether a review is needed. Judging at day three tells you nothing except whether you bruise.
Why does it last longer for some people than others?
Response varies with the area treated, the movement pattern, individual metabolism and how much movement the plan deliberately left. Your own interval is more useful than an average, which is why a first course is planned with a review rather than a fixed calendar.
Risks & Limitations
- Temporary brow or eyelid droop after treatment, which resolves as the effect wears off.
- Bruising, swelling or a brief headache at and after the injection sites.
- Asymmetry, or an unwanted change in expression, which may need review before it settles.
- All botulinum toxin results are temporary and maintenance treatment is required.
- Where filler is injected in the same session, vascular occlusion — a time-critical emergency that can cause skin loss and, rarely, vision loss — is an additional risk.
- No outcome can be guaranteed. Results vary with anatomy, movement pattern and healing.
When to Seek Care
- Difficulty breathing, difficulty swallowing or slurred speech after treatment — seek emergency care.
- Drooping eyelid, double vision, or weakness spreading beyond the treated area.
- Severe pain, or skin turning white, grey, mottled or dusky after a filler injection — a vascular emergency.
- Any change in vision — seek emergency care immediately.
- Fever, spreading redness, warmth or pus at an injection site.
References & Further Reading
- American Academy of Dermatology (AAD) — neurotoxin and injectable safety information
- American Society of Plastic Surgeons (ASPS) — injectable guidance
- U.S. Food and Drug Administration (FDA) — approved neurotoxin products and safety communications
- National Medical Products Administration (NMPA, China) — approved product status
- Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.